Pacific Biosciences of California Inc [NASDAQ: PACB] jumped around 0.13 points on Monday, while shares priced at $1.60 at the close of the session, up 8.84%. Compared to the average trading volume of 9.72M shares, PACB reached a trading volume of 8912618 in the most
Pacific Biosciences of California Inc [NASDAQ: PACB] gained 6.16% or 0.09 points to close at $1.55 with a heavy trading volume of 16792271 shares. The daily chart for PACB points out that the company has recorded -79.74% loss over the past six months. If we
Pacific Biosciences of California Inc [NASDAQ: PACB] stock went on a downward path that fall over -10.57% on Monday, amounting to a one-week price decrease of less than -17.83%. Over the last 12 months, PACB stock dropped by -75.33%. The one-year Pacific Biosciences of California
Pacific Biosciences of California Inc [NASDAQ: PACB] jumped around 0.16 points on Tuesday, while shares priced at $3.61 at the close of the session, up 4.64%. The company report on March 27, 2024 at 8:00 AM that Estonia National Biobank Selects PacBio to Sequence 10,000
Pacific Biosciences of California Inc [NASDAQ: PACB] price plunged by -2.67 percent to reach at -$0.1. The company report on March 27, 2024 at 8:00 AM that Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes. HiFi Data Generated on the Revio™ System will Support
Pacific Biosciences of California Inc [NASDAQ: PACB] price plunged by -2.49 percent to reach at -$0.09. The company report on March 22, 2024 at 4:30 PM that PacBio Grants Equity Incentive Award to New Employee. PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate
Pacific Biosciences of California Inc [NASDAQ: PACB] loss -0.82% on the last trading session, reaching $3.64 price per share at the time. The company report on March 12, 2024 at 9:05 AM that PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical
Pacific Biosciences of California Inc [NASDAQ: PACB] plunged by -$0.39 during the normal trading session on while it closed the day at $4.01. The company report on March 12, 2024 at 9:05 AM that PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End
Pacific Biosciences of California Inc [NASDAQ: PACB] traded at a low on Monday, posting a -5.97 loss after which it closed the day’ session at $4.88. The company report on February 26, 2024 at 4:05 PM that PacBio to Present at Upcoming Investor Conferences. PacBio
Pacific Biosciences of California Inc [NASDAQ: PACB] closed the trading session at $5.23. The company report on February 26, 2024 at 4:05 PM that PacBio to Present at Upcoming Investor Conferences. PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today
© 2024, Powered by Smart TechOne
